Drug Type Mesenchymal stem cell therapy |
Synonyms ET-STEM(Samsung Medical Center), Mesenchymal stem cells preconditioned with ethionamide(Samsung Medical Center) |
Target- |
Action- |
Mechanism Stem cell replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Frontotemporal Dementia | Phase 1 | South Korea | 06 Jul 2022 |